Skip to main content
. 2020 Jan 14;6(2):75–85. doi: 10.1093/ehjcvp/pvz086

Figure 5.

Figure 5

The risk of stroke or systemic embolism and major bleeding for patients using standard or reduced dose non-vitamin K antagonist oral anticoagulants. CI, confidence interval; Pys., person-years.